Structure-Toxicity Relationship in Intermediate Fibrils from α-Synuclein Condensates

Serene W. Chen,Joseph D. Barritt,Roberta Cascella,Alessandra Bigi,Cristina Cecchi,Martina Banchelli,Angelo Gallo,James A. Jarvis,Fabrizio Chiti,Christopher M. Dobson,Giuliana Fusco,Alfonso De Simone
DOI: https://doi.org/10.1021/jacs.3c14703
IF: 15
2024-04-04
Journal of the American Chemical Society
Abstract:The aberrant aggregation of α-synuclein (αS) into amyloid fibrils is associated with a range of highly debilitating neurodegenerative conditions, including Parkinson's disease. Although the structural properties of mature amyloids of αS are currently understood, the nature of transient protofilaments and fibrils that appear during αS aggregation remains elusive. Using solid-state nuclear magnetic resonance (ssNMR), cryogenic electron microscopy (cryo-EM), and biophysical methods, we here...
chemistry, multidisciplinary
What problem does this paper attempt to address?
The paper primarily investigates the structure-toxicity relationship of α-synuclein (αS) in the formation of pathological aggregates, especially its role in neurodegenerative diseases such as Parkinson's disease. The research focuses on the intermediate stage of αS transitioning from liquid globular aggregates to mature amyloid fibrils—intermediate fibrils—and their toxic effects on neuronal cells. Key findings of the paper include: 1. Intermediate fibrils form during the transformation of αS aggregates into mature amyloid fibrils, exhibiting a twisted morphology and possessing different structural and biological properties from mature amyloid fibrils. Intermediate fibrils are stabilized by a small anti-parallel β-sheet core, while the protein's N-terminal disordered region remains capable of mediating membrane binding. 2. In contrast, mature amyloid fibrils emerge in the subsequent aggregation process, displaying distinct structural and biological attributes, including lower cytotoxicity, a reorganized core structure embedding the N-terminal region, and a reduced tendency to interact with membranes. 3. The study characterized these two forms of fibrils using solid-state nuclear magnetic resonance (ssNMR), cryogenic electron microscopy (cryo-EM), and biophysical methods, revealing key molecular elements that endow intermediate fibrils, rather than mature aggregates, with the ability to interact with membranes and induce cytotoxicity. 4. The paper notes that intermediate fibrils induce significant levels of cytotoxicity when incubated with neuronal cells, whereas mature amyloid fibrils exhibit milder cytotoxic effects. This difference stems from the structuring of the N-terminal region in mature fibrils, rendering it no longer available for membrane binding and disruption of membrane integrity. 5. Further research found that the use of antibodies and designed mutants helped clarify the role of key structural elements that enable intermediate fibril species to interact with membranes and induce cytotoxicity. In summary, through detailed structural analysis and cellular experiments, the paper elucidates the intermediate fibril states of αS during the aggregation process and how these states affect neuronal cell health, providing important clues for understanding the pathogenesis of Parkinson's disease and other neurodegenerative disorders.